MAI Capital Management Has $4.07 Million Position in Cigna Group $CI

MAI Capital Management boosted its stake in shares of Cigna Group (NYSE:CI) by 52.5% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 14,124 shares of the health services provider’s stock after purchasing an additional 4,860 shares during the period. MAI Capital Management’s holdings in Cigna Group were worth $4,071,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Massachusetts Financial Services Co. MA boosted its stake in shares of Cigna Group by 1.1% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 11,778,472 shares of the health services provider’s stock valued at $3,893,727,000 after buying an additional 123,479 shares during the period. Dodge & Cox increased its stake in shares of Cigna Group by 0.7% in the second quarter. Dodge & Cox now owns 8,950,610 shares of the health services provider’s stock worth $2,958,893,000 after acquiring an additional 60,877 shares during the last quarter. Norges Bank purchased a new stake in shares of Cigna Group during the second quarter worth $1,110,426,000. Arrowstreet Capital Limited Partnership boosted its position in Cigna Group by 24.4% during the second quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock valued at $829,339,000 after purchasing an additional 492,045 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in Cigna Group by 0.7% in the second quarter. Charles Schwab Investment Management Inc. now owns 2,052,912 shares of the health services provider’s stock valued at $678,652,000 after purchasing an additional 15,014 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Up 1.7%

CI opened at $289.14 on Friday. The firm has a market cap of $77.24 billion, a P/E ratio of 13.04, a price-to-earnings-growth ratio of 0.99 and a beta of 0.27. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.74. The business has a 50 day moving average price of $279.63 and a 200 day moving average price of $284.45. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. The company had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the firm posted $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Research analysts forecast that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be paid a $1.56 dividend. The ex-dividend date is Thursday, March 5th. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio is presently 28.13%.

Analyst Ratings Changes

CI has been the subject of a number of recent research reports. UBS Group reaffirmed a “buy” rating and set a $375.00 price target on shares of Cigna Group in a research note on Monday, February 9th. Guggenheim restated a “buy” rating and issued a $318.00 price objective on shares of Cigna Group in a report on Monday, February 2nd. Barclays cut their price objective on shares of Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a research report on Friday, February 6th. Leerink Partners boosted their target price on shares of Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research report on Friday, February 6th. Finally, Cantor Fitzgerald dropped their price target on shares of Cigna Group from $365.00 to $325.00 in a research note on Friday, October 31st. One analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $330.63.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.